The results showed that the simultaneous treatment of proliferation-inducing concentrations of anti-CD95 and IL-2 in cervical tumour cells does not have a cumulative effect, which could suggest that both stimuli could be activating the same signalling pathways (Figure 3C,D). The gene discussed is IL2; the disease is uterine cervix neoplasm.